Suchergebnisse - "Kennedy, Nicholas A"

PubPharm (166)

1

Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis : protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine

enthalten in: BMJ open | 2024

von Wyatt, N. | Watson, H. | Anderson, C. | +47

2

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE) : a multicentre, open-label randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Noor, N. | Lee, J. | Bond, S. | +40

3

Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients

enthalten in: Journal of Crohn's & colitis | 2024

von Bai, B. | Reppell, M. | Smaoui, N. | +111

4

Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups : secondary analysis of a nationwide electronic survey

enthalten in: Journal of Crohn's & colitis | 2024

von Gebeyehu, G. | Taylor, F. | Dobson, L. | +5

5

Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research

enthalten in: Gut | 2024

von Alexander, J. | Wyatt, N. | Camuzeaux, S. | +23

6

Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis

enthalten in: Journal of Crohn's & colitis | 2023

von Yu, N. | Sriranganathan, D. | Walker, G. | +8

7

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis

enthalten in: Gut | 2023

von Akhlaghpour, M. | Haritunians, T. | More, S. | +142

CommentIn: Gut. 2023 Nov;72(11):2010-2012. - PMID 37098439

8

Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib

enthalten in: Journal of Crohn's & colitis | 2023

von Liu, Z. | Alexander, J. | Eng, K. | +31

9

Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies

enthalten in: Journal of Crohn's & colitis | 2023

von Verstockt, B. | Pivorunas, V. | Mahi, N. | +10

10

Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP) : a prospective, multicentre, cohort study

enthalten in: EClinicalMedicine | 2023

von Liu, Z. | Alexander, J. | Le, K. | +70

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]